Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

22.95 -0.05 (-0.22%)

Streaming Delayed Price Updated: 10:57 AM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

60 Biggest Movers From Yesterday ↗

February 18, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer...

Via Benzinga

35 Stocks Moving In Thursday's Mid-Day Session ↗

February 17, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares jumped 74.8% to $22.55. The company had a high redemption rate on its SPAC merger. Global-e Online Ltd. (NASDAQ: GLBE...

Via Benzinga

10x Genomics Shares Plunge On Disappointing Q4 Earnings, FY22 Outlook ↗

February 17, 2022

10x Genomics Inc (NASDAQ: TXG)

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 17, 2022

Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5...

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 17, 2022

Rise and shine, trader! It's time to wake up, grab a cup of coffee, and go over the biggest pre-market stock movers for Thursday!

Via InvestorPlace

Recap: 10x Genomics Q4 Earnings ↗

February 16, 2022

10x Genomics (NASDAQ:TXG) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 16, 2022 ↗

February 16, 2022

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.

Via Benzinga

25 Stocks Moving in Thursday's Pre-Market Session ↗

February 17, 2022

Gainers DoorDash, Inc. (NYSE: DASH) rose 24.3% to $117.94 in pre-market trading after the company reported better-than-expected Q4 sales results. Marin Software Incorporated...

Via Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

A Preview Of 10x Genomics's Earnings ↗

February 15, 2022

10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that 10x Genomics...

Via Benzinga

7 Stocks to Love for a Long, Long Time ↗

February 14, 2022

Although there are plenty of risks abound due to monetary and geopolitical pressures, there are discounts to be had for stocks to love.

Via InvestorPlace

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗

February 13, 2022

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

52 Weeks High And Low Article ↗

January 11, 2022

Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...

Via Benzinga

FedEx Options Trade & Stock Analysis ↗

December 19, 2021

This week we discuss last week's performance of our trades in the NUGT ETF. We also review our trade of FedEx after recent earnings.

Via Talk Markets

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

10x Genomics Stock: Bull vs. Bear ↗

November 24, 2021

After a hot start, the stock has recently lagged the market. Is now a good time to buy?

Via The Motley Fool

Topics Initial Public Offering

Notable 10X Genomics Insider Trades $2.8M In Company Stock ↗

November 17, 2021

Bradford Crutchfield, Insider at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 12, according to a new SEC filing. What Happened: A Form 4...

Via Benzinga

Topics Regulatory Compliance

Better Buy: 10x Genomics vs. DermTech ↗

November 11, 2021

Both companies offer disruptive new solutions in their niches of the healthcare space.

Via The Motley Fool

Chief Executive Officer Of 10X Genomics Trades $2.5M In Company Stock ↗

November 05, 2021

Serge Saxonov, Chief Executive Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 2, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

10x Genomics Clocks 74% Jump In Q3 Revenues; Raises Top End Of Sales Guidance ↗

November 04, 2021

10x Genomics Inc (NASDAQ: TXG) reported Q3 sales of $125.3 million, beating the consensus of $122.62 million. Sales increased 74% Y/Y, primarily due to increased...

Via Benzinga

10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

TXG earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Earnings Preview: 10x Genomics ↗

November 02, 2021

10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Notable 10X Genomics Insider Trades $2.7M In Company Stock ↗

October 15, 2021

Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing. What...

Via Benzinga

Topics Regulatory Compliance

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.